BI 1815368

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for BI 1815368, covering 2024-11-19 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema [Phase 2]